IRIS
MACCARRONE, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.614
AS - Asia 4.063
EU - Europa 2.216
SA - Sud America 338
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 28.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.544
SG - Singapore 2.766
CN - Cina 515
DE - Germania 326
RU - Federazione Russa 320
BR - Brasile 282
UA - Ucraina 279
IT - Italia 256
VN - Vietnam 218
HK - Hong Kong 215
IE - Irlanda 205
FR - Francia 183
SE - Svezia 144
GB - Regno Unito 130
PL - Polonia 117
KR - Corea 111
NL - Olanda 85
JP - Giappone 84
FI - Finlandia 71
IN - India 34
CA - Canada 30
MX - Messico 26
CZ - Repubblica Ceca 25
ZA - Sudafrica 23
BD - Bangladesh 17
AR - Argentina 16
IQ - Iraq 13
BE - Belgio 11
ES - Italia 11
EU - Europa 10
KG - Kirghizistan 10
AT - Austria 9
EC - Ecuador 9
AU - Australia 8
LT - Lituania 8
RS - Serbia 8
TR - Turchia 8
CL - Cile 7
ID - Indonesia 7
IR - Iran 7
UZ - Uzbekistan 7
IL - Israele 6
PY - Paraguay 6
VE - Venezuela 6
DK - Danimarca 5
PH - Filippine 5
CH - Svizzera 4
DM - Dominica 4
KZ - Kazakistan 4
PE - Perù 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
MA - Marocco 2
NG - Nigeria 2
NO - Norvegia 2
PK - Pakistan 2
QA - Qatar 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
Totale 28.293
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.865
Wilmington 5.561
Houston 4.808
Fairfield 804
Singapore 682
Ann Arbor 544
Ashburn 420
Chandler 375
Seattle 297
San Jose 268
Cambridge 248
Beijing 247
Jacksonville 242
Hong Kong 208
Dublin 201
Medford 157
Santa Clara 110
New York 104
Kraków 100
The Dalles 95
Los Angeles 85
Tokyo 75
Lawrence 74
Ho Chi Minh City 72
Dearborn 63
Rome 63
Hanoi 55
Council Bluffs 53
Buffalo 44
Dallas 44
Moscow 40
Mülheim 37
Lauterbourg 36
San Diego 33
São Paulo 33
Menlo Park 31
Munich 30
Zhengzhou 29
Orem 27
Milan 26
Brno 24
London 20
Chicago 18
Nuremberg 18
Redwood City 17
Chennai 16
Frankfurt am Main 16
Norwalk 16
San Mateo 16
Denver 15
Saint Petersburg 15
University Park 15
Falls Church 14
Mountain View 14
Stockholm 14
Brooklyn 13
Montreal 13
Warsaw 13
Phoenix 12
Redondo Beach 12
San Francisco 12
Atlanta 11
Brussels 11
Helsinki 11
Johannesburg 11
Kunming 11
Verona 11
Bari 10
Da Nang 10
Mexico City 10
Nanjing 10
North Bergen 10
Palo Alto 10
Columbus 9
Guangzhou 9
Seoul 9
Toronto 9
Boston 8
Curitiba 8
Haiphong 8
Nürnberg 8
Poplar 8
Rio de Janeiro 7
Salt Lake City 7
Shanghai 7
Belgrade 6
Biên Hòa 6
Boardman 6
Detroit 6
Hefei 6
Manchester 6
Berlin 5
Bắc Ninh 5
Jinan 5
Kyiv 5
Lappeenranta 5
Mcallen 5
Porto Alegre 5
Quito 5
Secaucus 5
Totale 22.913
Salva come PNG Salva come JPEG
Nome #
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 659
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 610
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 607
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
TRPV1 channels facilitate glutamate transmission in the striatum 596
Urinary N-acetyl-beta-D-glucosaminidase concentration in patients with spinal cord injury: relationship with urodynamic parameters 595
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 590
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 574
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 574
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 567
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 547
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 511
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 497
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour 485
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 484
Downstream effects of endocannabinoid on blood cells: Implications for health and disease 483
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 480
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 477
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 473
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 472
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 467
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 462
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 460
TRPV1 channels regulate cortical excitability in humans 460
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 453
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 439
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 439
Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity 437
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 436
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 432
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 432
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 429
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases 426
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons 425
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 423
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells . 423
HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids 419
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 414
The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases 412
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 410
The endocannabinoid system in targeting inflammatory neurodegenerative diseases 408
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis" 406
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 403
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 402
Altered anandamide degradation in attention-deficit/hyperactivity disorder 397
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases 394
null 393
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo 390
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 387
Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbance 384
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system 381
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 365
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity 282
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein 279
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 245
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System 224
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 219
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases 194
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 185
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 182
Platelet activation: a new vascular activity of anandamide [2] 174
The endocannabinoid hydrolase FAAH is an allosteric enzyme 159
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 159
Assay of NAPE-PLD Activity 152
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 150
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 125
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 122
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 116
Plant-Derived and Endogenous Cannabinoids in Epilepsy 108
Biochimica del sangue 107
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 91
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages 83
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes 78
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 74
Radiometric Assay of NAPE-PLD Activity 74
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 74
Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol 69
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 65
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 64
Fatty acid amide hydrolase, anandamide, and neurological diseases 63
Endocannabinoids and platelets - Signalling pathways 61
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential 60
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding 50
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 49
Endocannabinoids and platelets - Differentiation 44
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 33
Totale 28.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 90 144 56
2021/2022800 19 88 38 42 19 70 36 33 53 104 76 222
2022/2023937 107 81 19 122 69 230 73 60 87 4 64 21
2023/2024297 28 11 14 15 27 84 8 23 2 3 24 58
2024/20253.245 86 397 175 101 37 139 152 78 160 123 1.052 745
2025/20262.979 246 181 365 316 379 112 394 377 327 282 0 0
Totale 28.509